Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ursodeoxycholic acid + placebo
- Development stage
- Unknown
- Lead developer
- Daewoong Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
"Ursa tab. 200mg & CnU placebo cap. 250mg" is a co-administration regimen consisting of the active drug Ursa (ursodeoxycholic acid, 200 mg) and a matching placebo capsule (250 mg) for the investigational drug CnU. This regimen is used as the active comparator arm in a Phase 4 clinical trial (NCT07005752; MMP-401) sponsored by Myungmoon Pharm to evaluate the efficacy and safety of CnU (a combination of chenodeoxycholic acid and ursodeoxycholic acid) in patients with cholesterol cholelithiasis (radiolucent cholesterol gallstones). Ursodeoxycholic acid is a naturally occurring hydrophilic bile acid that acts as a litholytic agent by reducing biliary cholesterol saturation, thereby promoting the dissolution of cholesterol gallstones.
- Other names
- UDCA + placeboUrsa + placeboUrsa tab. 200mg & CnU placebo cap. 250mgursodeoxycholic acid + placebo
02
Targets
AKR1C2 (Aldo-keto reductase family 1 member C2)BLVRA (Biliverdin reductase A)GPBAR1FXR (Farnesoid x-activated receptor)SLC23A2 (Sodium-dependent vitamin C transporter 2)BAR (Bile acid receptor)
Beyond the preview
Go deeper on ursodeoxycholic acid + placebo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ursodeoxycholic acid + placebo.